Electronic versions

  • A.A. Sandoo
  • G. Kitas
  • T. Dimitroulas
  • A. Sandoo
  • J.P. Smith
  • G.D. Kitas
Rheumatoid Arthritis (RA) is associated with increased cardiovascular (CV) mortality and reduced life expectancy predominantly due to increased rates of acute coronary syndromes including unrecognized myocardial infractions [1]. The increased CV burden in this population has prompted rheumatologists and cardiologists to a more early and vigilant screening for CV risk stratification even in asymptomatic patients. Asymmetric dimethylarginine (ADMA) and subendocardial viability ratio (SEVR) represent non-invasive methods of assessing endothelial dysfunction and coronary microvascular perfusion to subendocardium respectively, two pivotal players in the development of CV disease and myocardial ischemia
Original languageEnglish
Pages (from-to)285-286
JournalInternational Journal of Cardiology
Issue number1
Publication statusPublished - 10 Jan 2014
View graph of relations